Tag Archives: Abbott

New Non-Profit Alliance of Big Pharma Firms

By Amy Ritter. Ten biopharmaceutical companies announced the formation of a nonprofit organization called TransCelerate BioPharma, the mission of which is to accelerate the development of new medicines by identifying and solving common drug development challenges.
Posted in Biotech, Deals, Guest Blog | Also tagged , , , , , , , , , | Leave a comment

Without An Rx, Some Pharmas Are Skittish

Lower margins and strong-arm direct-to-consumer campaigns are two of the primary barriers to selling nutraceuticals, according to a business school ‘war game’ conducted with the participation of Abbott, Danone (Dannon in the US), GSK and Nestlé. But the global nutraceuticals market – worth $80 billion in 2010, according to Frost & Sullivan – is expected […]
Posted in Advertising, Global, IP, Marketing, patient education, Regulatory, Strategy | Also tagged , , | 4 Comments

Abbott Shells Out $3.7 Billion for Piramal

In July 2009, judging solely by total revenue, Abbott was assigned the rank of the eighth-largest pharmaceutical company in the Fortune Global 500. Nearly a year later, the company is looking to move up at least a few notches. On May 21, Abbott acquired Indian generic giant Piramal for a cool $2.12 billion up front, […]
Posted in Strategy | Also tagged , , , , , , , , | Leave a comment

Saving Haiti: One Donation at a Time (UPDATED 1/21)

Image by American Red Cross via Flickr It’s been less than three days since new broke of a massive earthquake in Haiti that all but leveled the struggling country. With thousands dead, a devastated infrastructure, and no emergency plan, countries and businesses around the world have joined in the effort to help the Haitian people […]
Posted in News | Also tagged , , , , , , , | 2 Comments

Abbott to Purchase Solvay for $6.6 Billion (Update 1)

Abbott announced, early Monday morning, that it had signed a deal to purchase Belgium-based drug manufacturer Solvay Pharmaceuticals for $6.6 billion in cash—a mere five months after Solvay’s CEO Werner Cautreels announced that the company was searching for a proper suitor. The deal adds more than $3 billion in annualized sales to its global pharmaceutical […]
Posted in Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta